KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt issuances
Ratios

Medtronic (MDT) EBIAT (2016 - 2025)

Historic EBIAT for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $1.4 billion.

  • Medtronic's EBIAT rose 805.95% to $1.4 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $4.8 billion, marking a year-over-year increase of 1082.33%. This contributed to the annual value of $4.7 billion for FY2025, which is 2661.27% up from last year.
  • Per Medtronic's latest filing, its EBIAT stood at $1.4 billion for Q4 2025, which was up 805.95% from $1.0 billion recorded in Q3 2025.
  • In the past 5 years, Medtronic's EBIAT ranged from a high of $1.5 billion in Q2 2022 and a low of $435.0 million during Q4 2022
  • Its 5-year average for EBIAT is $1.1 billion, with a median of $1.2 billion in 2023.
  • Its EBIAT has fluctuated over the past 5 years, first surged by 16659.92% in 2021, then plummeted by 6697.04% in 2022.
  • Medtronic's EBIAT (Quarter) stood at $1.3 billion in 2021, then crashed by 66.97% to $435.0 million in 2022, then surged by 109.43% to $911.0 million in 2023, then soared by 40.29% to $1.3 billion in 2024, then increased by 8.06% to $1.4 billion in 2025.
  • Its EBIAT was $1.4 billion in Q4 2025, compared to $1.0 billion in Q3 2025 and $1.1 billion in Q2 2025.